RxDoctor Payments Data

Mitzi Groves, DO

Family Medicine · Stanley, KSNPI 1770577629

Payments from drug & device makers

$8,376in general payments, 2019–2025

Across 607 payments — averaging $13.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$907
  • Amarin Pharma, Inc.$761
  • Amgen$629
  • AstraZeneca$423
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$8,370100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,376 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$74,617
Medicare patients
200
Services billed
1,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$38,725
JardianceEmpagliflozin34$37,877
MounjaroTirzepatide27$36,566
MyrbetriqMirabegron19$14,939
EliquisApixaban16$13,078
XareltoRivaroxaban17$8,719
VascepaIcosapent Ethyl12$5,619
SynthroidLevothyroxine Sodium53$4,272
Omega-3 Acid Ethyl Esters27$2,591
Celecoxib28$1,724
Atorvastatin Calcium211$1,529
Escitalopram Oxalate102$1,518
Bupropion XlBupropion Hcl51$1,262
Pantoprazole Sodium65$1,028
Estradiol26$1,025

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,098$38,72540 claims
Boehringer IngelheimJardiance$32$37,87734 claims
Lilly USA, LLCMounjaro$907$36,56627 claims
Astellas Pharma US IncMyrbetriq$37$14,93919 claims
PfizerEliquis$281$13,07816 claims
AbbVieSynthroid$1,539$4,27253 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$981152 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Stanley

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →